DECON7 SYSTEMS, LLC – Trademark Portfolio
Entity Type: 16
DECON7 SYSTEMS, LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 15 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include D7, BDAS, SMART FOAM, DECON SEVEN, and QUICKSTRIKE. The owner is based in SCOTTSDALE, AZ.
7575 EAST REDFIELD ROAD
SUITE 235
SCOTTSDALE, AZ 85260
Showing of trademarks Trademarks
Trademark Classifications
DECON7 SYSTEMS, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does DECON7 SYSTEMS, LLC have?
DECON7 SYSTEMS, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 10 registered, 3 abandoned, 2 cancelled.
What trademark classes does DECON7 SYSTEMS, LLC file in?
DECON7 SYSTEMS, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 37 (Building & Construction), Class 40 (Treatment & Processing). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are DECON7 SYSTEMS, LLC's most well-known trademarks?
DECON7 SYSTEMS, LLC's registered trademark portfolio includes well-known marks such as D7, BDAS, SMART FOAM, DECON SEVEN, and QUICKSTRIKE. These are among 10 currently registered trademarks in the portfolio.
What is DECON7 SYSTEMS, LLC's trademark registration success rate?
DECON7 SYSTEMS, LLC has a 67% trademark registration rate, with 10 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.